Section Navigation
Section Navigation
- Module 8 Overview
HCV Test and Cure - 0%Lesson 1
Epidemiology and Natural HistoryActivities- 0%Lesson 2
Screening, Diagnosis, and PreventionActivities- 2A.Core Concepts
- 2B.Interpretation of HCV Diagnostic Laboratory Test Results
- 2C.Strategies for Implementing Hepatitis C Virus Point-of-Care Testing
- 0%Lesson 3
Pretreatment Evaluation and Fibrosis StagingActivities- 3A.Core Concepts
- 3B.FibroScan: A Clinician's Guide
- 3C.Calculating FIB-4 Score
- 3D.Calculating a CTP Score
- 0%Lesson 4
HCV Simplified TreatmentActivities- 4A.Core Concepts
- 4B.HCV Point of Care Testing and the Test and Treat Approach
- 4C.Simplified Treatment Criteria
- 4D.Recommended Regimens for Simplified Treatment Approach
- 4E.Follow up After the HCV Test and Treat Approach
- 4F.Initiation of HCV Treatment in Person with Alcohol Use Disorder
- 4G.Glecaprevir-Pibrentasvir Treatment with Compensated Cirrhosis
- 4H.Sofosbuvir-Velapatasvir Treatment with Compensated Cirrhosis
- 4I.Drug Interactions with Glecaprevir-Pibrentasvir
- 4J.Drug Interactions with Sofosbuvir-Velpatasvir
- 4K.Management of Treatment Interruption with less than 7 Missed Days
- 4L.Management of Treatment Interruption After Missing 8-20 Days
- 0%Lesson 5
Follow-Up and Promoting Liver HealthActivity 4E. Follow up After the HCV Test and Treat Approach
Learning Objective Performance Indicators
- Provide a rationale for treating all people with HCV except persons with less than a 12-month life expectancy
- Adhere to inclusion and exclusion criteria for who is eligible to receive simplified HCV treatment
- Choose an appropriate recommended regimen for simplified HCV treatment
- Conduct laboratory monitoring for persons receiving simplified HCV treatment, including assessment for sustained virologic response
- Manage incomplete treatment adherence based on time into treatment and number of days of missed doses
Instructions
Instructions: Watch this brief video by Dr. Andrew Aronsohn on Follow up After the HCV Test and Treat Approach (6 minutes). Dr. Aronsohn is a Co-Chair for the AASLD-IDSA Hepatitis C Guidance.Activity Question
You should answer this question after completing the activity.You must answer all of the questions before checking your work.
This activity has a Check on Learning question. - Show QuestionWhat is the next step for a patient who completes the HCV simplified treatment and has an HCV RNA level of 1,390 copies/mL obtained 4 weeks after completing HCV therapy?
Share by e-mail
Check
-On-
Learning
QuestionsThe Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.You must be signed in to customize your interaction with these questions.
- 0%Lesson 2
Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhcvc-monorepo-75ec26d4-2025-04-30-205728
Become a New User
Account Registration Benefits:
- Track your progress on the lessons
- Earn free CNE/CME/CE
- Earn Certificates of Completion
- Access to other free IDEA curricula
Create a free account to get started